Pfizer vaccine 'highly effective' against severe Covid Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid - including the Delta variant - for at least six months, ... Coronavirus • 05 Oct
EMA to decide on Pfizer booster vaccine on Monday The EMA will decide on Monday whether to approve Pfizer's Covid-19 booster vaccine, but it is unlikely to give precise guidance on who should receive ... Coronavirus • 29 Sep
US FDA grants Pfizer Covid-19 vaccine full approval The US drug regulator has granted full approval to the Pfizer/BioNTech Covid-19 vaccine, making it the first to secure such Food and Drug Administration validation ... Coronavirus • 23 Aug
Pfizer, Moderna could reap billions from booster shots Drugmakers Pfizer, BioNTech and Moderna are expected to reap billions of dollars from Covid-19 booster shots in a market that could rival the $6 billion ... Business • 13 Aug
Pfizer and Moderna raise vaccine prices in EU - report Pfizer and Moderna have raised the prices of their Covid-19 vaccines in the latest European Union supply contracts, according to a report in The Financial ... Coronavirus • 01 Aug
Pfizer raises forecast for Covid vaccine sales Pfizer has raised its forecast for sales of the Covid-19 vaccine that it developed with Germany's BioNTech by 28.8% to $33.5 billion, as countries scramble ... Business • 28 Jul
GSK's drugs arm to get £8 billion booster from spin-off GSK has set out its plans to turn its consumer healthcare arm into a separately listed company, in a move that will deliver an £8 ... Business • 24 Jun
US to donate 500 million vaccines to poorest countries US President Joe Biden has pledged that America will be the "arsenal of vaccines, as it was the arsenal of democracy in World War II" ... Coronavirus • 10 Jun
Pfizer lifts sales forecast for Covid vaccine to $26bn Pfizer has forecast $26 billion in Covid-19 vaccine sales this year, a more than 70% jump from its last projection, reflecting new contracts with governments ... Business • 04 May
EU looks to secure 1.8bn 2nd-generation vaccine doses The EU is about to start negotiations with a single pharmaceutical company to secure up to 1.8 billion doses of a "second generation" mRNA vaccine ... Coronavirus • 09 Apr
Pfizer, BioNTech say jab can stand warmer temperatures BioNTech and its US partner Pfizer have said tests have shown that their Covid-19 vaccine can stand warmer temperatures than initially thought, potentially simplifying the ... Coronavirus • 19 Feb
EU buys up to 300 million more Moderna jabs The European Commission has said it had struck a deal for an extra 150 million doses of Moderna's Covid-19 vaccine this year, nearly doubling the ... World • 17 Feb
Pfizer sees $15 billion in 2021 sales from vaccine Pfizer said today that it expected to generate $15 billion, or about a quarter of its total revenue this year, from the sale of its ... Business • 02 Feb
Pfizer delay to have 'modest' impact on vaccine rollout The Head of the Covid-19 National Vaccine Taskforce has said there will only be a modest impact to the rollout of the vaccination programme by ... Coronavirus • 15 Jan
EMA may approve AstraZeneca vaccine by end of month Europe's medicines regulator has said it expects drug maker AstraZeneca to apply for approval of its Covid-19 vaccine next week. Coronavirus • 08 Jan
From the lab to the jab: The BioNTech-Pfizer vaccine It was over breakfast on the wintry morning of 24 January that Ozlem Tureci and her husband Ugur Sahin decided, "we need to fire the ... Coronavirus • 26 Dec 20
US FDA staff back Pfizer's coronavirus vaccine data Pfizer has cleared the next hurdle in the race to get its Covid-19 vaccine approved for emergency use after the US Food and Drug Administration ... Coronavirus • 08 Dec 20
Cabinet approves purchase of Moderna Covid vaccine The Cabinet has approved an advance purchase agreement for 875,000 doses of the Covid-19 vaccine produced by Moderna. Coronavirus • 01 Dec 20
Pfizer/BioNTech to seek emergency approval for vaccine Pfizer and its partner BioNTech confirmed they will apply for emergency use authorisation for their coronavirus vaccine, becoming the first to do so in the ... Coronavirus • 20 Nov 20
Pfizer ends Covid-19 trial with 95% efficacy Pfizer has said that final results from the late-stage trial of its Covid-19 vaccine show it is 95% effective, adding it had the required two ... Coronavirus • 18 Nov 20
Buffett's Berkshire bets on Big Pharma Warren Buffett's Berkshire Hathaway said it has begun investing in the stocks of four large drugmakers, betting on an industry that could benefit when the ... Business • 17 Nov 20
What progress is being made with Covid-19 vaccines? Here is everything you need to know about the coronavirus vaccine race. Coronavirus • 09 Nov 20
Medical experts cautiously optimistic over vaccine news There has been a cautiously optimistic reaction from medical experts after Pfizer said its experimental vaccine was more than 90% effective in preventing Covid-19 based ... News Lens • 09 Nov 20
World markets soar on coronavirus vaccine hopes World stock markets soared today on hopes of a coronavirus vaccine following successful trials by pharmaceutical company, Pfizer. Business • 09 Nov 20
Pfizer to create 300 jobs in Dublin, Kildare and Cork Pfizer is creating about 300 new jobs at its manufacturing sites in Grange Castle in Co Dublin, Newbridge in Co Kildare and Ringaskiddy in Co ... Business • 02 Nov 20
